TrialThe oncologist2023

The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.

C Mircea S Tesileanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.